Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy (Q84987063)
Jump to navigation
Jump to search
scientific article published on 23 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy |
scientific article published on 23 September 2011 |
Statements
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy (English)
R Hein
S Abbas
P Seibold
R Salazar
D Flesch-Janys
23 September 2011